[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574780":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":22,"locations":29,"responsibleParty":44,"collaborators":46,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":21,"eligibilityCriteria":55,"healthyVolunteers":52,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":21,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":31,"whyStopped":21,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental group","EXPERIMENTAL","Prospective, single-arm study",[13],"Drug: Systane COMPLETE",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Systane COMPLETE","Preop dry eye management using Systane COMPLETE can help to optimize the ocular surface.",[9],[9],null,[23],{"name":24,"role":25,"phone":26,"phoneExt":27,"email":28},"Chiun Ho Hou, Ph.D","CONTACT","+88623123456","262131","chiunhohou@gmail.com",[30],{"facility":5,"status":31,"city":32,"state":33,"zip":21,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","Taipei","Taiwan","TW",{"type":36,"coordinates":37},"Point",[38,39],121.52639,25.05306,{"lat":39,"lon":38},[42],{"name":43,"role":25,"phone":26,"phoneExt":27,"email":28},"Chiun Ho MD Hou",{"type":45,"investigatorFullName":21,"investigatorTitle":21,"investigatorAffiliation":21,"oldNameTitle":21,"oldOrganization":21},"SPONSOR",[47],{"name":48,"class":49},"Alcon Research","INDUSTRY","100574780","phase-4-optimizing-the-ocular-surface-with-systane-complete-in-patients-with-dry-eye-planning-for-cataract-surgery-100574780",false,"NCT06763731","Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery","Inclusion Criteria:\n\nThe subjects aged 20-85 years, with normal cognitive function and capable of answering related questionnaires who require phacoemulsification and intraocular lens implantation under topical anaesthesia, are the eligible candidates.\n\nExclusion Criteria:\n\n1. Unable to answer the questions in the dry eye survey.\n2. Ocular trauma or ocular surgery in the planned surgical eye, active ocular infection, and obvious abnormalities in ocular surface or eyelid margins other than MGD cause decreased visual acuity other than cataracts.\n3. Dry eye signs: Corneal Fluorescein Staining CFS (+) to exclude any corneal abnormalities or epithelial defect\n4. Systemic drug use, including tetracycline derivatives, antihistamines, and isotretinoin.\n5. Using dry eye medication at screening stage","ALL","20 Years","85 Years",{"count":60,"type":61},150,"ESTIMATED","INTERVENTIONAL",[64],"PHASE4","Regular use of Systane COMPLETE in dry eye subjects before cataract surgery may optimize the ocular surface.",[67],"Ophthalmology",[69,70],"Dry eye","Cataract surgery","2026-04-21",{"date":73,"type":74},"2026-04-23","ACTUAL",{"date":76,"type":74},"2024-05-02",{"date":78,"type":61},"2027-12-31",{"name":5,"class":6},1]